期刊名称：EXPERT REVIEW OF CLINICAL IMMUNOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Through recent research advances we are increasingly able to understand and address immune-mediated diseases. Biotechnology is yielding success in areas with a strong immunologic component, such as allergic asthma, rheumatoid arthritis, inflammatory bowel disease, psoriasis and multiple sclerosis. Nevertheless, the burden of immune-mediated diseases is still enormous, with direct and indirect costs associated with such conditions believed to exceed $100 billion in the USA alone.
Expert Review of Clinical Immunology (ISSN 1744-666X) provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in clinical immunology. Members of the International Editorial Advisory Panel of Expert Review of Clinical Immunology are the forefront of their area of expertise. This panel works with our dedicated editorial team to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology.
Articles focus on the following key areas:
Therapeutic overviews of specific immunologic disorders highlighting optimal therapy and prospects for new medicines
Performance and benefits of newly approved therapeutic agents
New diagnostic approaches
Screening and patient stratification
Pharmacoeconomic studies
New therapeutic indications for existing therapies
Adverse effects, occurrence and reduction
Prospects for medicines in late-stage trials approaching regulatory approval
Novel treatment strategies
Epidemiological studies
Commentary and comparison of treatment guidelines
Indexing
EMBASE/Excerpta Medica
Chemical Abstracts
MEDLINE/Index Medicus
Scopus
Instructions to Authors
ExpertReviewsAuthorGuidelines_forweb.pdf
Editorial Board
Editorial Advisory Panel
Bieber T, University of Bonn, Germany
Blaiss MS, University of Tennessee Health Science, USA
Bonini S, University of Rome, Italy
Bousquet J, Montpellier University, France
Calhoun WJ, University of Texas Medical Branch, TX, USA
Canonica GW, Genoa University, Italy
Carlsen KH, National Hospital, Norway
Casale TB, Creighton University, USA
Clerici M, Universita degli Studi di Milano, Italy
Clotet B, Hospital Universitari Germans Trias i Pujol, Spain
Corr M, University of California, USA
Crofford LJ, University of Kentucky, KY, USA
Diamanti A, Bambino Gesu Children Hospital, Italy
Emery P, Leeds General Infirmary, UK
Forsthuber T, University of Texas at San Antonio, USA
Gordon KB, Loyola University Medical Center, USA
Hamid Q, McGill University, Canada
Hanauer SB, University of Chicago, USA
Hommes OR, European Charcot Foundation, The Netherlands
Kowalski M, Medical University of Lodz, Poland
Langley RG, Dalhousie University, NS, Canada
Ledford DK, University of South Florida, USA
Mitsuyasu RT, University of California, Los Angeles, USA
Nkengasong JN, Centers for Disease Control and Prevention, USA
Notarangelo LD, Children's Hospital Boston, MA, USA
Papp KA, Probity Medical Research, Canada
Pawankar R, Nippon Medical School, Japan
Petrovsky N, Flinders Medical Centre, Australia
Preiksaitis JK, University of Alberta, Canada
Radstake T, University Medical Centre Nijmegen, Netherlands
Raine CS, Albert Einstein College of Medicine, USA
Rothenberg ME, Cincinnati Children's Hospital Medical Center, OH, USA
Sauder DN, Robert Wood Johnson School of Medicine, NJ, USA
Stepkowski SM, The University of Texas Medical School at Houston, USA
von Herrath MG, La Jolla Institute for Allergy and Immunology, USA
Zhao Y, Chinese Academy of Sciences, China
|
